Physician

Ashley M Crane, M.D.

According to 2025 Medicare claims, Ashley Crane, M.D. (NPI: 1225460371) practices ophthalmology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is PAUTLER COHEN FINDLAY EICHENBAUM WHITE AND CRANE MDS PA (NPI: 1881712859; TIN: 591501675) and primary practice location at 33756-6256.

Crane's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 642 traditional Medicare patients, billed 40,196 HCPCS/CPT codes, and received $1,453,157 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 377 prescription claims across 137 beneficiaries totaling $14,667 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 72 records totaling $83,929. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,923 to $1,453,157. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $11,233 and ending at $14,667. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$727K$1.5M2017 Medicare payment: $5,923 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $24,611 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $158,980 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $470,346 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $698,690 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $982,717 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $933,706 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,453,157 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017137157$5,923
2018173234$24,611
20192171,037$158,980
20202702,705$470,346
20213873,778$698,690
20224606,914$982,717
202345116,198$933,706
202464240,196$1,453,157

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$41K2015 Drug cost: $11,233 (USD; Tot_Drug_Cst)2016 Drug cost: $22,898 (USD; Tot_Drug_Cst)2017 Drug cost: $17,549 (USD; Tot_Drug_Cst)2018 Drug cost: $28,966 (USD; Tot_Drug_Cst)2019 Drug cost: $41,172 (USD; Tot_Drug_Cst)2020 Drug cost: $15,585 (USD; Tot_Drug_Cst)2021 Drug cost: $16,402 (USD; Tot_Drug_Cst)2022 Drug cost: $14,615 (USD; Tot_Drug_Cst)2023 Drug cost: $13,755 (USD; Tot_Drug_Cst)2024 Drug cost: $14,667 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201581243$11,233
201675292$22,898
201799348$17,549
2018166467$28,966
2019152696$41,172
202067201$15,585
202170204$16,402
202291273$14,615
202399287$13,755
2024137377$14,667

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye227722$93
92014Established patient complete exam of visual system405677$92
92134Imaging of retina5421,242$30
92250Photography of the retina391499$28
92201Extended exam of the back part of the eye with retinal drawing228468$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1044,581$4,409
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha961,997$899
Ketorolac TromethamineKetorolac Tromethamine26902$885
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat322,038$332
Brimonidine TartrateBrimonidine Tartrate262,054$221

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.65$13,227ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.7$70,702Ocular Therapeutix, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ashley M. Crane, M.D.?

Tedicare shows public-source Medicare data for Ashley M. Crane, M.D. (NPI 1225460371), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashley M. Crane, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ashley M. Crane, M.D.?

Ashley M. Crane, M.D. is linked to PAUTLER COHEN FINDLAY EICHENBAUM WHITE AND CRANE MDS PA (billing NPI 1881712859) in the available physician profile data.

Does Ashley M. Crane, M.D. have Open Payments data?

Ashley M. Crane, M.D. has 72 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.